Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BREMER

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Leukemia|June 11, 2020
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammationF La Rosée, H C Bremer, I Gehrke, et al.
Cancer|August 7, 2016
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohortPhuong L Mai, Ana F Best, June A Peters, et al.
International Journal of Cancer|November 9, 2017
Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research DatalinkYoujin Wang, Ruth M Pfeiffer, Rotana Alsaggaf, et al.
Plos Neglected Tropical Diseases|December 31, 2020
Diagnostic accuracy of direct agglutination test, rK39 ELISA and six rapid diagnostic tests among visceral leishmaniasis patients with and without HIV coinfection in EthiopiaMekibib Kassa, Saïd Abdellati, Lieselotte Cnops, et al.
The New England Journal of Medicine|September 8, 1994
An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jailC W Hoge, M R Reichler, E A Dominguez, et al.
JAMA Oncology|August 4, 2017
Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome CohortPhuong L Mai, Payal P Khincha, Jennifer T Loud, et al.
Family Process|October 25, 2019
Family Health Leaders: Lessons on Living with Li-Fraumeni Syndrome across GenerationsAshley Pantaleao, Jennifer L Young, Norman B Epstein, et al.
Journal of Psychosocial Oncology|December 29, 2018
Couples coping with screening burden and diagnostic uncertainty in Li-Fraumeni syndrome: Connection versus independenceJennifer L Young, Ashley Pantaleao, Lori Zaspel, et al.
BMC Psychiatry|February 6, 2022
Towards optimal treatment selection for borderline personality disorder patients (BOOTS): a study protocol for a multicenter randomized clinical trial comparing schema therapy and dialectical behavior therapyCarlijn J M Wibbelink, Arnoud Arntz, Raoul P P P Grasman, et al.
Frontiers in Cellular and Infection Microbiology|January 9, 2019
Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal LeishmaniasisTegwen Marlais, Tapan Bhattacharyya, Om Prakash Singh, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Leukemia|June 11, 2020
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammationF La Rosée, H C Bremer, I Gehrke, et al.
Cancer|August 7, 2016
Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohortPhuong L Mai, Ana F Best, June A Peters, et al.
International Journal of Cancer|November 9, 2017
Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research DatalinkYoujin Wang, Ruth M Pfeiffer, Rotana Alsaggaf, et al.
Plos Neglected Tropical Diseases|December 31, 2020
Diagnostic accuracy of direct agglutination test, rK39 ELISA and six rapid diagnostic tests among visceral leishmaniasis patients with and without HIV coinfection in EthiopiaMekibib Kassa, Saïd Abdellati, Lieselotte Cnops, et al.
The New England Journal of Medicine|September 8, 1994
An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jailC W Hoge, M R Reichler, E A Dominguez, et al.
JAMA Oncology|August 4, 2017
Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome CohortPhuong L Mai, Payal P Khincha, Jennifer T Loud, et al.
Family Process|October 25, 2019
Family Health Leaders: Lessons on Living with Li-Fraumeni Syndrome across GenerationsAshley Pantaleao, Jennifer L Young, Norman B Epstein, et al.
Journal of Psychosocial Oncology|December 29, 2018
Couples coping with screening burden and diagnostic uncertainty in Li-Fraumeni syndrome: Connection versus independenceJennifer L Young, Ashley Pantaleao, Lori Zaspel, et al.
BMC Psychiatry|February 6, 2022
Towards optimal treatment selection for borderline personality disorder patients (BOOTS): a study protocol for a multicenter randomized clinical trial comparing schema therapy and dialectical behavior therapyCarlijn J M Wibbelink, Arnoud Arntz, Raoul P P P Grasman, et al.
Frontiers in Cellular and Infection Microbiology|January 9, 2019
Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal LeishmaniasisTegwen Marlais, Tapan Bhattacharyya, Om Prakash Singh, et al.
Pageof 7